Sanjivani Paranteral Ltd. | Small-cap | Healthcare
₹223.05
0.27%
| Sanjivani Paranteral Stock Comparison:
Sanjivani Paranteral vs Sun PharmaceuticalSanjivani Paranteral vs Divi's LaboratoriesSanjivani Paranteral vs Innova CaptabSanjivani Paranteral vs Suven Life SciencesSanjivani Paranteral vs Gujarat ThemisSanjivani Paranteral vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 178.9M
Gross Profit 67.8M 37.88%
Operating Income 24.8M 13.88%
Net Income 17.3M 9.67%
EPS (Diluted) ₹1.41

Balance Sheet Metrics

Total Assets 782.0M
Total Liabilities 383.3M
Shareholders Equity 398.7M
Debt to Equity 0.96

Cash Flow Metrics

Revenue & Profitability Trend

Sanjivani Paranteral Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i695.6M536.9M352.4M303.8M247.1M
Cost of Goods Sold i444.0M328.0M218.2M152.4M166.4M
Gross Profit i251.6M208.9M134.2M151.4M80.7M
Gross Margin % i36.2%38.9%38.1%49.8%32.7%
Operating Expenses
Research & Development i5.7M646.2K0--
Selling, General & Administrative i77.1M85.7M45.9M58.8M23.9M
Other Operating Expenses i1.4M-610.7K-2.5M8.4M220.8K
Total Operating Expenses i84.2M85.8M43.4M67.2M24.1M
Operating Income i97.3M74.8M48.0M44.8M25.1M
Operating Margin % i14.0%13.9%13.6%14.8%10.1%
Non-Operating Items
Interest Income i3.3M324.2K74.0K41.5K166.3K
Interest Expense i4.1M1.2M2.3M832.6K78.2K
Other Non-Operating Income-----
Pre-tax Income i103.5M75.7M49.4M48.8M14.1M
Income Tax i22.6M14.1M4.3M321.5K-71.5K
Effective Tax Rate % i21.8%18.6%8.8%0.7%-0.5%
Net Income i80.9M61.7M45.1M48.5M14.2M
Net Margin % i11.6%11.5%12.8%16.0%5.7%
Key Metrics
EBITDA i113.9M87.8M60.7M54.7M35.1M
EPS (Basic) i₹6.89₹5.28₹4.51₹4.85₹1.67
EPS (Diluted) i₹6.66₹5.28₹4.51₹4.85₹1.67
Basic Shares Outstanding i1175299011684300999830099983008498300
Diluted Shares Outstanding i1175299011684300999830099983008498300

Income Statement Trend

Sanjivani Paranteral Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i14.9M5.4M3.0M3.4M1.7M
Short-term Investments i9.3M90.2M3.4M--
Accounts Receivable i166.8M47.0M19.9M49.2M66.3M
Inventory i105.1M97.3M53.5M17.5M9.1M
Other Current Assets---4.9M11.7M
Total Current Assets i341.8M286.4M82.7M77.3M91.8M
Non-Current Assets
Property, Plant & Equipment i386.4K386.4K386.4K386.4K361.3K
Goodwill i1.6M0000
Intangible Assets i782.0K----
Long-term Investments-----
Other Non-Current Assets--17.0K--
Total Non-Current Assets i440.2M147.7M127.4M105.7M100.9M
Total Assets i782.0M434.1M210.1M183.0M192.8M
Liabilities
Current Liabilities
Accounts Payable i152.5M57.4M137.2M114.4M105.9M
Short-term Debt i28.5M017.3M32.4M407.5M
Current Portion of Long-term Debt-----
Other Current Liabilities121.5M70.2M64.2M97.4M96.8M
Total Current Liabilities i317.9M137.8M226.5M218.9M576.3M
Non-Current Liabilities
Long-term Debt i52.9M9.7M7.6M27.5M53.0M
Deferred Tax Liabilities i7.7M3.5M3.1M9.2M8.8M
Other Non-Current Liabilities-2-1-11-1
Total Non-Current Liabilities i65.3M17.3M14.3M39.9M65.4M
Total Liabilities i383.3M155.1M240.8M258.8M641.7M
Equity
Common Stock i118.8M116.8M100.0M100.0M85.0M
Retained Earnings i-427.9M-508.9M-570.5M-615.6M-664.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i398.7M279.0M-30.7M-75.8M-448.9M
Key Metrics
Total Debt i81.4M9.7M24.9M59.9M460.6M
Working Capital i23.9M148.6M-143.9M-141.7M-484.4M

Balance Sheet Composition

Sanjivani Paranteral Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i103.5M75.7M49.4M48.8M14.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-69.4M-99.9M-32.2M33.9M-19.8M
Operating Cash Flow i35.9M-23.6M19.0M83.5M-5.7M
Investing Activities
Capital Expenditures i-303.5M-33.0M-10.5M-6.8M-4.3M
Acquisitions i0----
Investment Purchases i--90.2M---
Investment Sales i81.0M500.0K---
Investing Cash Flow i-123.6M-122.8M-10.5M-6.8M-4.3M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i71.7M----
Debt Repayment i0---91.0M-28.5M
Financing Cash Flow i109.7M248.0M0-76.0M-2.5M
Free Cash Flow i-179.5M-140.1M35.9M78.4M1.5M
Net Change in Cash i22.1M101.7M8.5M689.5K-12.6M

Cash Flow Trend

Sanjivani Paranteral Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.50
Price to Book 7.12
Price to Sales 3.91
PEG Ratio -50.71

Profitability Ratios

Profit Margin 11.34%
Operating Margin 13.88%
Return on Equity 20.31%
Return on Assets 10.35%

Financial Health

Current Ratio 1.08
Debt to Equity 20.42
Beta -0.88

Per Share Data

EPS (TTM) ₹6.60
Book Value per Share ₹31.98
Revenue per Share ₹60.66

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sanjivin2.8B34.507.1220.31%11.34%20.42
Sun Pharmaceutical 4.0T37.735.4215.08%19.29%3.26
Divi's Laboratories 1.6T67.5710.4014.64%23.89%0.03
Innova Captab 48.6B37.445.0713.37%9.98%35.24
Suven Life Sciences 48.0B-28.3141.36-146.15%84.44%0.00
Gujarat Themis 46.2B103.1518.5519.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.